Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

Clinical trial NCT05356897 · WITHDRAWN

Trial details

NCT number: NCT05356897
Sponsor: Academic and Community Cancer Research United
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colon Adenocarcinoma Metastatic Colorectal Adenocarcinoma Metastatic Rectal Adenocarcinoma Stage IV Colon Cancer AJCC V8 Stage IV Colorectal Cancer AJCC V8 Stage IV Rectal Cancer AJCC V8

Start date: 2023-10-31
Primary completion: 2024-09-17
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.